reference/9984040

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9984040

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	246
issn	0140-6736
issueIdentifier	9787
pageRange	238-246
publicationName	Lancet (London, England)
startingPage	238
bibliographicCitation	Molina JM, Cahn P, Grinsztejn B, Lazzarin A, Mills A, Saag M, Supparatpinyo K, Walmsley S, Crauwels H, Rimsky LT, Vanveggel S, Boven K; ECHO study group. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial. Lancet. 2011 Jul 16;378(9787):238–46. doi: 10.1016/s0140-6736(11)60936-7. PMID: 21763936.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_27c007ee4f6026c72d2fec397ca02b11 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f8faf65ec357426d37369362e8ac7988 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6d73d144e0d11a66ca87efdc399dd85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ceae3dbde93c3567b887b7ec04e4078 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e55d3a550b9a4b0829e0a65835aaf60 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_130daf9d69c97d3664ccdfb067f21d30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d2138f244cf50e7f935a1db55658116 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df0af654bd741470d496eab1ec5627e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_512ce366d5370ba9c8a587db36d85d39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab7c976b30d95ae5319f3166cce96aee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5372ba07407fcac576308382670fbc16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9dfb7791f1c318ae45770893b69d0639
date	2011-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/21763936 https://doi.org/10.1016/s0140-6736%2811%2960936-7
isPartOf	https://portal.issn.org/resource/ISSN/0140-6736 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0028255 http://id.nlm.nih.gov/mesh/M0337569 http://id.nlm.nih.gov/mesh/M0005491 http://id.nlm.nih.gov/mesh/M0254881 http://id.nlm.nih.gov/mesh/M0503898 http://id.nlm.nih.gov/mesh/M0014878 http://id.nlm.nih.gov/mesh/M0000347 http://id.nlm.nih.gov/mesh/M0482137 http://id.nlm.nih.gov/mesh/M0258297 http://id.nlm.nih.gov/mesh/M0461882 http://id.nlm.nih.gov/mesh/M0028839 http://id.nlm.nih.gov/mesh/M0005997 http://id.nlm.nih.gov/mesh/M0000724 http://id.nlm.nih.gov/mesh/M0571031
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451164 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464205 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60877 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6398764 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246357805 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129727356 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127945305 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129233080 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129722732 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621

Total number of triples: 58.